Cargando…

Effect of Xinyue capsules on patients with coronary heart disease after percutaneous coronary intervention: study protocol for a randomized controlled trial

BACKGROUND: The risk of cardiovascular events remains high in patients with coronary heart disease (CHD) after successful percutaneous coronary intervention (PCI). Panax quinquefolius saponin, a major component of Xinyue capsule, has been used to treat patients with CHD. The aim of this study is to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Ming, Zi, Ming-jie, Xi, Rui-xi, Yang, Qiao-ning, Bai, Rui-na, Zhang, Yi-sheng, Wang, Yu-hua, Wang, Pei-li, Shi, Da-zhuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991005/ https://www.ncbi.nlm.nih.gov/pubmed/27538952 http://dx.doi.org/10.1186/s13063-016-1531-x

Ejemplares similares

Efficacy and Safety of Xinyue Capsule for Coronary Artery Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Jiang, Zhonghui, et al.
Publicado: (2021)

Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis
por: Liu, Qiao, et al.
Publicado: (2021)

Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial
por: Li, Jingen, et al.
Publicado: (2018)

Predictive value of miRNA-21 on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Dai, Haiyue, et al.
Publicado: (2021)

Design and Rationale of the National Tunisian Registry of Percutaneous Coronary Intervention: Protocol for a Prospective Multicenter Observational Study
por: Hammami, Rania, et al.
Publicado: (2022)

Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial
por: Zhou, Tienan, et al.
Publicado: (2023)

Preservation of Xinyu Tangerines with an Edible Coating Using Ficus hirta Vahl. Fruits Extract-Incorporated Chitosan
por: Chen, Chuying, et al.
Publicado: (2019)

Clinical prognosis of optimal medical therapy after percutaneous coronary intervention in patients with coronary heart disease
por: Hao, Jing-Yan, et al.
Publicado: (2021)

Study of the Mechanism of Action of Guanxin Shutong Capsules in the Treatment of Coronary Heart Disease Based on Metabolomics
por: Wang, Dan, et al.
Publicado: (2021)

Panic disorder and incident coronary heart disease: a systematic review and meta-analysis protocol
por: Tully, Phillip J, et al.
Publicado: (2015)

Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: study protocol for a double-blind, randomized controlled trial
por: Wang, Yongxia, et al.
Publicado: (2020)

Songling Xuemaikang capsules for patients with low-to-medium risk hypertension: study protocol for a randomized controlled trial
por: Jiang, Yuerong, et al.
Publicado: (2019)

Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial
por: JIANG, Xiao-Si, et al.
Publicado: (2020)

The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Wang, Lexun, et al.
Publicado: (2021)

Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
por: Li, Yongjun, et al.
Publicado: (2022)

Development of a preprocedure nomogram for predicting contrast-induced acute kidney injury after coronary angiography or percutaneous coronary intervention
por: Guo, Bao-Liang, et al.
Publicado: (2017)

The effect of door-to-balloon delay in primary percutaneous coronary intervention on clinical outcomes of STEMI: a systematic review and meta-analysis protocol
por: Foo, Chee Yoong, et al.
Publicado: (2016)

Effects of chronic obstructive pulmonary disease on long-term prognosis of patients with coronary heart disease post-percutaneous coronary intervention
por: YAO, Yi, et al.
Publicado: (2022)

Double product reflects the association of heart rate with MACEs in acute coronary syndrome patients treated with percutaneous coronary intervention
por: Xu, Tan, et al.
Publicado: (2017)

The percutaneous coronary intervention prior to transcatheter aortic valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial
por: Khawaja, Muhammed Zeeshan, et al.
Publicado: (2014)

Clinical characteristics and factors affecting the duration of positive nucleic acid test for patients of COVID‐19 in XinYu, China
por: Lu, Jingjing, et al.
Publicado: (2020)

Prognostic value of quantitative flow ratio in patients with coronary heart disease after percutaneous coronary intervention therapy: a meta-analysis
por: Chen, Huaigang, et al.
Publicado: (2023)

Effects of traditional Chinese exercise on cardiac rehabilitation after percutaneous coronary intervention: study protocol for network meta-analysis of randomised controlled trials
por: Luo, Chuanjin, et al.
Publicado: (2019)

Collaborative care for the treatment of comorbid depression and coronary heart disease: a systematic review and meta-analysis protocol
por: Tully, Phillip J, et al.
Publicado: (2014)

Effect of preoperative coronary CT for planning of percutaneous coronary intervention for complex chronic total occlusion (CTS-C-CTOPCI): study protocol for an open-label randomised controlled trial
por: La Scala, Eugenio, et al.
Publicado: (2023)

MRI tracking stem cells transplantation for coronary heart disease
por: Lu, Xi, et al.
Publicado: (2014)

Influence of sex on outcomes after percutaneous coronary intervention in patients over 75 years of age with coronary heart disease
por: Liu, Yuqi, et al.
Publicado: (2014)

Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC): Intervention Development and Protocol for the Process Evaluation
por: Östbring, Malin Johansson, et al.
Publicado: (2018)

Optimal strategy of primary percutaneous coronary intervention for acute myocardial infarction due to unprotected left main coronary artery occlusion (OPTIMAL): study protocol for a randomised controlled trial
por: Gao, Yang, et al.
Publicado: (2019)

Lessons from transulnar access for repeat percutaneous coronary intervention after radial artery occlusion
por: Bi, Xi-Le, et al.
Publicado: (2020)

Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Chu, Xin, et al.
Publicado: (2021)

Initiate Danhong Injection before or after percutaneous coronary intervention for microvascular obstruction in ST-elevation myocardial infarction (DIRECTION): study protocol for a randomized controlled trial
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

Coronary risk reduction intervention for siblings and offspring of patients with premature coronary heart disease: the CRISO study protocol for a randomised controlled pilot study
por: Mifsud, Justin Lee, et al.
Publicado: (2021)

An exploration of proactive health oriented symptom patterns in patients undergoing percutaneous coronary intervention with stent implantation: A mixed-methods study protocol
por: Wang, Qi, et al.
Publicado: (2023)

Heme oxygenase-1 gene promoter polymorphisms are associated with coronary heart disease and restenosis after percutaneous coronary intervention: a meta-analysis
por: Zhang, Ming-Ming, et al.
Publicado: (2016)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

The relationship between hyperuricemia and contrast-induced acute kidney injury undergoing primary percutaneous coronary intervention: secondary analysis protocol for the ATTEMPT RESCIND-1 study
por: Guo, Wei, et al.
Publicado: (2020)

Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) retrospective study of coronary catheterisation and percutaneous coronary intervention
por: Li, Jing, et al.
Publicado: (2014)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Chronic Total Occlusion of Coronary Arteries: A Systematic Review and Meta-Analysis
por: Wang, Chenyang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_muq0cg8s8hpco89ap7tbnptqku